These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8748415)

  • 21. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
    Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
    Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboxane mediates the ischemia-induced neutrophil oxidative burst.
    Paterson IS; Klausner JM; Goldman G; Kobzik L; Welbourn R; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1989 Aug; 106(2):224-9. PubMed ID: 2527418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of thromboxane synthase inhibition on reperfusion injury and endothelin-1,2 levels in allograft kidney transplantation in rats.
    Büyükgebiz O; Aktan AO; Haklar G; Bilsel S; Dülger M
    Res Exp Med (Berl); 1999 Apr; 198(6):289-98. PubMed ID: 10369085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
    Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
    J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of Radix salviae miltiorrhizae on reperfusion injury and hepatocyte apoptosis in donor liver after orthotopic liver transplantation in rats].
    Wang Y; Zhou J; Jiang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):870-3. PubMed ID: 18504224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.
    Man K; Fan ST; Lo CM; Liu CL; Fung PC; Liang TB; Lee TK; Tsui SH; Ng IO; Zhang ZW; Wong J
    Ann Surg; 2003 Feb; 237(2):256-64. PubMed ID: 12560784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective thromboxane A2 synthetase inhibition in vasospastic angina pectoris.
    Yui Y; Hattori R; Takatsu Y; Kawai C
    J Am Coll Cardiol; 1986 Jan; 7(1):25-9. PubMed ID: 3941213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation.
    Fukunaga K; Takada Y; Taniguchi H; Yuzawa K; Otsuka M; Todoroki T; Goto K; Fukao K
    Int Surg; 1998; 83(3):226-31. PubMed ID: 9870780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
    Austin JC; Berrizbeitia LD; Schoen FJ; Kauffman RP; Hechtman HB; Cohn LH
    Am Heart J; 1988 Mar; 115(3):505-9. PubMed ID: 3344655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs.
    Ishitsuka Y; Moriuchi H; Hatamoto K; Yang C; Takase J; Golbidi S; Irikura M; Irie T
    J Pharm Pharmacol; 2004 Apr; 56(4):513-20. PubMed ID: 15099446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances.
    Goto M; Takei Y; Kawano S; Nagano K; Tsuji S; Masuda E; Nishimura Y; Okumura S; Kashiwagi T; Fusamoto H
    Hepatology; 1994 Mar; 19(3):675-81. PubMed ID: 8119692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of prostanoid in hepatic damage during hepatectomy.
    Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence of reperfusion influences ischemia/reperfusion injury and primary graft function following porcine liver transplantation.
    Brockmann JG; August C; Wolters HH; Hömme R; Palmes D; Baba H; Spiegel HU; Dietl KH
    Liver Transpl; 2005 Oct; 11(10):1214-22. PubMed ID: 16184569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.
    Monbaliu D; Vekemans K; Hoekstra H; Vaahtera L; Libbrecht L; Derveaux K; Parkkinen J; Liu Q; Heedfeld V; Wylin T; Deckx H; Zeegers M; Balligand E; Buurman W; van Pelt J; Porte RJ; Pirenne J
    Ann Surg; 2009 Nov; 250(5):808-17. PubMed ID: 19826248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of primary nonfunction after canine liver allotransplantation: the effect of gadolinium chloride.
    Chung KY; Jeong GY; Choi KB; Sung SH; Kim YS
    Transplant Proc; 2004 Sep; 36(7):1928-30. PubMed ID: 15518701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of N-acetylcysteine on apoptosis induced by myocardial ischemia reperfusion injury in rats' heart transplantation].
    Yi X; Cui X; Wu P; Wang S; Wang G; Yang X; Yang F; Zheng S; Li Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Oct; 27(10):1234-9. PubMed ID: 24397138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.